PTS Diagnostics’ Patent Enforcement Against Jant Pharmacal Gains Momentum
United States International Trade Commission opens investigation of Jant Pharmacal Corporation’s LipidPlus Meter and LipidPlus Profile test strips
Indianapolis, IN – Nov. 6, 2015 – PTS Diagnostics’ patent infringement enforcement efforts against Jant Pharmacal Corp. gained significant momentum today as the U.S. International Trade Commission (ITC) instituted an investigation of Jant and its suppliers: Infopia America, LLC and Infopia Co., Ltd. of South Korea (Infopia).
The ITC is an independent U.S. federal agency charged by Congress to investigate unfair trade practices that impact U.S. domestic industries. It has announced it will investigate Jant following a review of PTS Diagnostics’ allegations that the cholesterol test strips that include an HDL test and meters that Jant and Infopia are importing into and selling in the U.S. infringe PTS Diagnostics’ U.S. patent no. 7,087,397.
“We are very proud of how the healthcare industry has embraced our CardioChek lipid measurement system. The CardioChek family of products has screened more than 120 million patients worldwide,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “PTS Diagnostics remains committed to protecting ourselves against this and any future patent infringements.”
Recognizing the strong connection between heart attack, stroke, and diabetes, CardioChek analyzers provide rapid point-of-care blood-chemistry values and measurements to help identify at-risk individuals. As one of the fastest, most cost-efficient and user-friendly analyzers on the market today, CardioChek systems accurately test lipid profile and glucose simultaneously with one fingerstick. In as little as 90 seconds, they provide on-site results with similar accuracy to clinical laboratories.
PTS Diagnostics’ PTS Panels lipid test strips measure total cholesterol, HDL cholesterol, and triglycerides, calculate LDL cholesterol and TC/HDL ratio, and do not require refrigeration. The accompanying meter is handheld, battery-operated, and compact and lightweight, making it easy to transport and store. CardioChek systems are CLIA-waived and meet NCEP guidelines for accuracy and precision. The CardioChek Plus analyzer offers simultaneous testing of lipid profile and glucose, has wireless communication capabilities, and is CRMLN-certified for total cholesterol and HDL cholesterol testing.
PTS Diagnostics expects that the ITC will conduct a hearing in its investigation of Jant and Infopia’s importation of cholesterol test strips that include an HDL panel and meters in 2016.